Royalty Pharma (RPRX) Selling, General & Administrative (2019 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Selling, General & Administrative (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.91 Bn | 45.24 Bn | 4.68 Bn | 1.24 Bn |
| 2 | Royalty Pharma | 36.78 Bn | 38.89 Bn | - | 161.89 Mn |
| 3 | Royal Gold | 22.19 Bn | 22.06 Bn | 390.45 Mn | 13.45 Mn |
| 4 | OR Royalties | 6.98 Bn | 6.91 Bn | 82.22 Mn | -4.93 Mn |
| 5 | Encore Capital | 2.06 Bn | 1.88 Bn | 455.04 Mn | 38.72 Mn |
| 6 | Atlanticus Holdings | 1.41 Bn | 853.17 Mn | 686.46 Mn | - |
| 7 | Jefferson Capital | 1.23 Bn | 1.21 Bn | - | - |
| 8 | Upbound | 1.11 Bn | 1.00 Bn | 594.84 Mn | 59.68 Mn |
| 9 | Lufax Holding | 1.08 Bn | -1.19 Bn | - | -47.69 Mn |
| 10 | Metalla Royalty & Streaming | 957.79 Mn | 946.72 Mn | 4.75 Mn | -1.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 161.89 Mn |
| Mar 31, 2026 | 159.49 Mn |
| Dec 31, 2025 | 164.27 Mn |
| Sep 30, 2025 | 118.73 Mn |
| Jun 30, 2025 | 179.77 Mn |
| Mar 31, 2025 | 110.71 Mn |
| Dec 31, 2024 | 67.59 Mn |
| Sep 30, 2024 | 56.72 Mn |
| Jun 30, 2024 | 54.71 Mn |
| Mar 31, 2024 | 57.65 Mn |
| Dec 31, 2023 | 59.19 Mn |
| Sep 30, 2023 | 57.23 Mn |
| Jun 30, 2023 | 47.63 Mn |
| Mar 31, 2023 | 85.70 Mn |
| Dec 31, 2022 | 73.23 Mn |
| Sep 30, 2022 | 50.69 Mn |
| Jun 30, 2022 | 51.84 Mn |
| Mar 31, 2022 | 51.54 Mn |
| Dec 31, 2021 | 46.16 Mn |
| Sep 30, 2021 | 48.59 Mn |